Elutia (Nasdaq:ELUT) announced today that it entered into a securities purchase agreement worth total proceeds of $26.2 million. The drug-eluting biomatrix company expects the private placement financing to result in initial gross proceeds of approximately $10.5 million. The full exercise of warrants would add $15.8 million to reach a total of $26.2 million. Silver Spring, […]
Regenerative Medicine
FDA clears rotator cuff repair implant from Anika Therapeutics
Anika Therapeutics (Nasdaq:ANIK) announced that it received the final FDA 510(k) clearance for its Integrity implant system. Bedford, Massachusetts-based Anika designed Integrity to augment an injured tendon, promoting healing in rotator cuff repair procedures. This clearance for the hyaluronic acid (HA)-based patch component joins previous clearances for associated fixation devices and instruments. The company describes […]
Coloplast to acquire wound care company Kerecis for $1.3B
Coloplast announced today that it entered into an agreement to sign Kerecis, a developer of biologics for the wound care market. The agreement has a total value reaching up to $1.3 billion. Of that, Coloplast intends to pay $1.2 billion in an upfront cash payment. Denmark-based Coloplast sees Kerecis as an “attractive opportunity” to strengthen […]
BioCardia seeks Japanese approval of heart failure cell therapy
BioCardia (Nasdaq:BCDA) announced today that it completed the submission of its CardiAMP cell therapy system to Japan’s regulatory authorities. Sunnyvale, California-based BioCardia submitted CardiAMP to Japan’s Pharmaceutical and Medical Device Agency (PMDA). It seeks approval for the indication of ischemic heart failure with reduced ejection fraction (HFrEF). It expects a formal consultation with PMDA to […]
MiMedx appoints Joseph Capper as CEO
MiMedx (Nasdaq:MDXG) today announced it appointed Joseph Capper as CEO and director, effective immediately. He replaces interim CEO Todd Newton, who was appointed in September 2022. Newton will remain in his role on the Board of Directors at the Marietta, Georgia–based advanced wound care and therapeutic biologics company. Capper has nearly 30 years of medtech and […]
MiMedx appoints chief operating officer
MiMedx (Nasdaq:MDXG) announced that it appointed Ricci S. Whitlow as its chief operating officer (COO). Whitlow’s responsibilities include leading manufacturing, supply chain, procurement, quality and regulatory efforts. She joins from Catalent, where she most recently served as president of clinical supply services. “We are happy to begin 2023 with the addition of Ricci Whitlow to […]
MiMedx stock rises on Q3 sales beat
MiMedx (Nasdaq:MDXG) shares rose this morning on third-quarter results that beat the consensus revenue forecast. Shares of MDXG ticked up 5.8% at $2.92 apiece in early-morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell by 4.2%. The Marietta, Georgia-based regenerative medicine company posted losses of […]
Bone Biologics prices $5.1M offering
Bone Biologics (Nasdaq:BBLG) announced today that it priced an underwritten public offering worth $51. million. The offering includes nearly 3.8 million units of securities. Each unit costs $1.35. The gross proceeds total $5.1 million before deducting underwriting discounts and commissions, plus other offering expenses. Each unit features one share of common stock. They also include […]
MiMedx CEO is leaving, interim replacement named
MiMedx (Nasdaq:MDXG) announced today that Timothy Wright will depart as CEO, with board member K. Todd Newton set to serve in an interim role. Wright served as MiMedx’s CEO since May 2019. Newton holds the interim position while the company’s board appointed a special committee to conduct a search for a new CEO. The search […]
Integra founder Richard Caruso has died
Integra LifeSciences (Nasdaq:IART) today announced the passing of Richard Caruso, its founder and former chair and CEO. NJBIZ says he was 79. Caruso founded Princeton, New Jersey–based Integra in 1989 with the aim of enabling the human body to regenerate its own damaged or diseased tissue. According to a news release, Caruso paved the way […]
Orthofix announces first clinical use of its autograft substitute
Orthofix Medical today announced the limited market release and first implant of its Virtuos Lyograft autograft substitute. Lewisville, Texas-based Orthofix designed Virtuos Lyograft as a shelf-stable and complete autograft substitute for spine and orthopedic procedures. It is prepared by MTF Biologics through a process that preserves all biologic components needed for bone healing within the […]
